Colin Bartel

Colin Bartel is the Chief Financial Officer at Surfix Diagnostics, a company that has developed an ultrasensitive photonic biosensor. Apart from their current role, Colin also serves as a Supervisory Board member at Fokker Technologies Group B.V. and is the owner and co-investor at W6 Finance. Colin has extensive experience in various financial roles, including positions at IamFluidics BV, Micronit Microtechnologies, and OPRA Technologies. Prior to these roles, Colin worked at AkzoNobel, The Growth Factory, Accenture, and Parcom Capital, where Colin gained valuable experience and expertise. Educated at Rotterdam School of Management, Erasmus University, and Queen's University, Colin holds an MBA, a Master’s Degree in Business Informatics, and a Bachelor of Science in Life Sciences.